Westford, USA, Aug. 04, 2022 (GLOBE NEWSWIRE) — Schizophrenia affects about 1% of the population and is predicted to become more common in the future as the world becomes crowded and people live longer. As per latest WHO, more than 24 million people around the globe are affected by schizophrenia each year. They the most potential consumers in the global schizophrenia drugs market. Wherein, the prevalence is extremely high among people in late adolescence and the twenties. As per SkyQuest analysis, men are more likely to suffer from the condition earlier than female. The study also suggests that people with the condition are 2-3 times more likely to die early than general population.
The increasing prevalence of schizophrenia is a serious public health concern. It is a brain disorder that affects the way people think, feel, and act and is often characterized by hallucinations (seeing things that are not really there), delusions (beliefs that are not true), and impaired social or communication skills.
Fortunately, there is ongoing research into new treatments for schizophrenia. And in some cases, existing treatments may help to improve someone’s quality of life. SkyQuest has a published a report on global schizophrenia drugs market that covers a deeper market analysis, available treatment option, consumption and availability of drugs, market analysis by type of drugs and their demand, presence of market players and their growth strategies. Apart from this the report…
